PCAOB Deficiency Tracker
← Back to Explorer

De Leon & Company, P.A.

United States · Triennially Inspected

Inspection year
2019
Report date
18-Mar-2021
PCAOB release
104-2021-082
Audits reviewed
2
Audits w/ Part I.A deficiencies
2
Part I.A deficiency rate
100%
Part I.A deficiencies
7
Part I.B deficiencies
3
Report
View PDF ↗

Deficiencies (7)

Grouped by issuer and in the same order as the PCAOB report, so each item ties back directly to the source.

Issuer A5 deficiencies

#AreaDeficiencyStandardFlags
1Convertible Notes and WarrantsThe issuer issued convertible notes and related warrants. Certain of the convertible notes included discounts. The issuer did not recognize a derivative liability or beneficial conversion feature associated with any of the convertible notes or warrants. The following deficiencies were identified: · The firm did not perform procedures to test the valuation of the convertible notes or warrants. (AS 2502.15)
Financial statement audit only
AS 2502.15
2Convertible Notes and WarrantsThe issuer issued convertible notes and related warrants. Certain of the convertible notes included discounts. The issuer did not recognize a derivative liability or beneficial conversion feature associated with any of the convertible notes or warrants. The following deficiencies were identified: · The firm did not evaluate whether the issuer's accounting for the convertible notes was appropriate including whether (1) the conversion options related to the convertible notes should have been separated and accounted for as derivatives in conformity with FASB ASC Subtopic 815-15 Derivatives and Hedging — Embedded Derivatives or (2) the convertible notes should have been bifurcated into a liability component and the embedded conversion option (including consideration of a potential beneficial conversion feature) in conformity with FASB ASC Subtopic 470-20 Debt — Debt with Conversion and Other Options. (AS 2810.30)
Financial statement audit only
AS 2810.30
3Convertible Notes and WarrantsThe issuer issued convertible notes and related warrants. Certain of the convertible notes included discounts. The issuer did not recognize a derivative liability or beneficial conversion feature associated with any of the convertible notes or warrants. The following deficiencies were identified: · The firm did not evaluate whether the issuer's accounting for the warrants was in accordance with GAAP. (AS 2810.30)
Financial statement audit only
AS 2810.30
4Convertible Notes and WarrantsThe issuer issued convertible notes and related warrants. Certain of the convertible notes included discounts. The issuer did not recognize a derivative liability or beneficial conversion feature associated with any of the convertible notes or warrants. The following deficiencies were identified: · The firm did not test the number and valuation of the shares issued upon conversion and evaluate whether the conversions were recorded and presented appropriately. (AS 2301.08; AS 2810.30)
Financial statement audit only
AS 2301.8; AS 2810.30
5Other Equity-Based TransactionsThe firm did not perform sufficient procedures to test expenses for other equity-based transactions because it did not (1) obtain an understanding of the terms of the arrangements (2) evaluate whether the expenses were recorded in the proper period and (3) evaluate whether the expenses were appropriately valued in accordance with GAAP. (AS 2301.08; AS 2810.30)
Financial statement audit only
AS 2301.8; AS 2810.30

Issuer B2 deficiencies

#AreaDeficiencyStandardFlags
1RevenueTo test revenue the firm selected sales transactions for testing that exceeded a monetary threshold. The firm did not perform any procedures to test the remaining population of sales transactions. (AS 1105.27)
Financial statement audit only
AS 1105.27
2RevenueTo test revenue the firm selected sales transactions for testing that exceeded a monetary threshold. For the sales transactions selected for testing the firm did not evaluate whether all of the relevant revenue recognition criteria had been met. (AS 2301.08)
Financial statement audit only
AS 2301.8